Zoetis News and Activities

Presence

Zoetis develops and sells animal health medicines, vaccines, diagnostic products, and related services. It serves livestock producers and pet owners through veterinarians, clinics, and animal health professionals.

Zoetis products and services overview:

Animal medicines
Animal vaccines
Diagnostic products
Pet care
Livestock health
Genetic testing

Revenue: ~$9 billion

Employees: 13,800

Headquarters: Parsippany, United States (USA)

Zoetis is one of the...

Zoetis is a company listed under the stock ticker ZTS (US).

Zoetis has a direct presence in 7 countries.

Zoetis has 7 subsidiaries including Zoetis Canada & Latin America, Zoetis Denmark and Zoetis Diagnostics.

They are in:

Acquisition, funding and merger involving Zoetis.

Zoetis has announced the acquisition of Neogen (posted on March 2 2026).

Executives

View the org chart displaying its 79 main executives

Most searched biographies at Zoetis

Popular executive movements at Zoetis

Robert Polzer, Executive Vice President and President of Research & Development, will retire on Dec. 1, 2025 (posted on November 4 2025).
Kevin Esch will join the company as Executive Vice President and President, Research and Development on Jan. 1, 2026 (posted on November 4 2025).
Stephanie Tilenius will join the company as Director on Dec. 1, 2025 (posted on October 29 2025).

Create your alert
to follow the executive moves at Zoetis.